NetworkNewsBreaks – Adaptimmune Therapeutics plc (NASDAQ: ADAP) Secures $84M in Underwritten Public Offering

Adaptimmune Therapeutics (NASDAQ: ADAP), a leader in T-cell therapy to treat cancer, has closed an underwritten public offering of 21,000,000 of its American Depositary Shares (“ADSs”). According to the update, Adaptimmune Therapeutics secured gross proceeds of $84 million in the offering, with each of the ADSs sold at the public offering price of $4.00. Adaptimmune has, in connection with the offering, granted the underwriters a 30-day option to purchase up to an additional 3,150,000 ADSs at the public offering price. All ADSs in this offering are sold by Adaptimmune Therapeutics, which intends to use the proceeds to advance the development of its immunotherapies into and through clinical trials as well as for other general corporate purposes. ROTH Capital Partners acted as co-manager for the offering.

To view the full press release, visit

About Adaptimmune Therapeutics plc

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The Company’s unique SPEAR(R) (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors. For more information, please visit

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire is part of the InvestorBrandNetwork.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.